Port Chester, NY, United States of America

Andre J Marozsan

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andre J Marozsan

Introduction

Andre J Marozsan is an accomplished inventor based in Port Chester, NY (US). He has made significant contributions to the field of medical science, particularly in the development of therapies for bacterial infections. His innovative work has led to the creation of a patent that addresses critical health issues.

Latest Patents

Andre J Marozsan holds 1 patent related to reagents, compositions, and therapies designed to treat infections and related disease conditions. This patent specifically focuses on addressing issues such as associated diarrhea caused by bacterial infections and the enterotoxins produced by these bacteria. The invention includes antibodies or antigen-binding fragments that bind specifically to toxin A and/or toxin B, neutralizing their activities. The patent also encompasses compositions comprising these antibodies and methods for their use.

Career Highlights

Andre is currently associated with Progenics Pharmaceuticals, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise and dedication to research have positioned him as a valuable asset in the field.

Collaborations

Throughout his career, Andre has collaborated with talented individuals such as Dangshe Ma and Kirsten Nagashima. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking therapies.

Conclusion

Andre J Marozsan's contributions to medical science through his patent and work at Progenics Pharmaceuticals, Inc. highlight his commitment to improving health outcomes. His innovative approaches to treating bacterial infections demonstrate the importance of research and collaboration in advancing medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…